UNSPSC 85892563: High dose rate (hdr) brachytherapy of left breast using iridium 192 (ir-192)

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of high dose rate (hdr) brachytherapy of left breast using iridium 192 (ir-192). This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code DM1098Z

UNSPSC 85892563 High dose rate (hdr) brachytherapy of left breast using iridium 192 (ir-192) is a Commodity code that shows a mismatch between its nominal scope and recent state and local procurement activity. The code's technical name indicates specialized oncology radiation therapy, but the single recent opportunity available does not align with brachytherapy procurement. Instead, the County of Santa Clara Health System posted a qualification-based RFQ (RFSQHHSFY270052) in July 2026 for temporary health professional staffing services across multiple ancillary clinical categories—audiology, diagnostic imaging and radiology, gastroenterology, orthopedics, respiratory care, sterile processing, surgical and operating room support, and therapy services among others. The Health System explicitly excludes nursing, physician, and non-clinical staffing from the solicitation and is establishing a non-exclusive, multiple-award qualified vendor pool with no guaranteed work volume; placement on the qualified list does not guarantee contract award.

The code shows minimal relevant recent activity for state and local procurement. The single posting originates from a California county health system, and the scope—temporary ancillary clinical staffing—falls outside the brachytherapy treatment services the UNSPSC code nominally describes. Proposals for the Santa Clara Health System opportunity were due October 7, 2026, with qualifications and scope to be negotiated case-by-case between each selected vendor and the County. This code does not currently reflect active state and local procurement of radiation oncology services, brachytherapy equipment, or related clinical procedures.